Form 8-K GILEAD SCIENCES INC For: Jul 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Gilead Sciences (GILD) Tops Q2 EPS by 41c, Updates Guidance
July 26, 2017 4:05 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $2.56, $0.41 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.14 billion versus the consensus estimate of $6.35 billion.
GUIDANCE:
Gilead Sciences sees FY2017 revenue of $24-25.5 billion, versus the consensus of $24.8... More



